Mari Nordbø Gynnild

12PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Decision makingDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 05, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

|Jun 01, 2026
Response by Omland et al to Letter Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial".

|Feb 09, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score.

Joris Holtrop, Mari N Gynnild, Matthew Richards

|Jan 30, 2026
Three-year adherence to secondary prevention and vascular risk control after ischemic stroke.

Erlend Fagerli, Hanne Ellekjær, Olav Spigset

|Aug 30, 2025
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Torbjørn Omland, Siri Lagethon Heck, Espen Holte

|Aug 26, 2025
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients.

Joris Holtrop, Mari Nordbø Gynnild, Toril Dammen

Pageof 2

Frequent Collaborators

6 joint publications

Ingvild Saltvedt

5 joint publications

Steven H J Hageman

4 joint publications

Jannick A N Dorresteijn

4 joint publications

Hanne Ellekjær